ID   RBP1_RAT                Reviewed;         647 AA.
AC   Q62796; O55195;
DT   15-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   24-JUL-2024, entry version 164.
DE   RecName: Full=RalA-binding protein 1 {ECO:0000303|PubMed:7623849};
DE            Short=RalBP1 {ECO:0000303|PubMed:7623849};
DE   AltName: Full=Cytocentrin {ECO:0000303|PubMed:9973605};
DE   AltName: Full=Dinitrophenyl S-glutathione ATPase {ECO:0000250|UniProtKB:Q15311};
DE            Short=DNP-SG ATPase {ECO:0000250|UniProtKB:Q15311};
DE            EC=7.6.2.2 {ECO:0000250|UniProtKB:Q15311};
DE            EC=7.6.2.3 {ECO:0000250|UniProtKB:Q15311};
DE   AltName: Full=Ral-interacting protein 1;
GN   Name=Ralbp1 {ECO:0000312|RGD:621134};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH RALA, TISSUE
RP   SPECIFICITY, AND DOMAIN.
RC   TISSUE=Brain;
RX   PubMed=7623849; DOI=10.1128/mcb.15.8.4578;
RA   Cantor S.B., Urano T., Feig L.A.;
RT   "Identification and characterization of Ral-binding protein 1, a potential
RT   downstream target of Ral GTPases.";
RL   Mol. Cell. Biol. 15:4578-4584(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND SUBCELLULAR LOCATION.
RX   PubMed=9973605; DOI=10.1242/jcs.112.5.707;
RA   Quaroni A., Paul E.C.A.;
RT   "Cytocentrin is a Ral-binding protein involved in the assembly and function
RT   of the mitotic apparatus.";
RL   J. Cell Sci. 112:707-718(1999).
RN   [3]
RP   INTERACTION WITH REPS1, AND REGION.
RC   TISSUE=Muscle;
RX   PubMed=9395447; DOI=10.1074/jbc.272.50.31230;
RA   Yamaguchi A., Urano T., Goi T., Feig L.A.;
RT   "An eps homology (EH) domain protein that binds to the ral-GTPase target,
RT   RalBP1.";
RL   J. Biol. Chem. 272:31230-31234(1997).
RN   [4]
RP   FUNCTION, INTERACTION WITH REPS2, AND REGION.
RC   TISSUE=Brain;
RX   PubMed=9422736; DOI=10.1074/jbc.273.2.814;
RA   Ikeda M., Ishida O., Hinoi T., Kishida S., Kikuchi A.;
RT   "Identification and characterization of a novel protein interacting with
RT   Ral-binding protein 1, a putative effector protein of Ral.";
RL   J. Biol. Chem. 273:814-821(1998).
RN   [5]
RP   FUNCTION.
RX   PubMed=10393179; DOI=10.1093/emboj/18.13.3629;
RA   Nakashima S., Morinaka K., Koyama S., Ikeda M., Kishida M., Okawa K.,
RA   Iwamatsu A., Kishida S., Kikuchi A.;
RT   "Small G protein Ral and its downstream molecules regulate endocytosis of
RT   EGF and insulin receptors.";
RL   EMBO J. 18:3629-3642(1999).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48; SER-62 AND SER-463, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Multifunctional protein that functions as a downstream
CC       effector of RALA and RALB. As a GTPase-activating protein/GAP can
CC       inactivate CDC42 and RAC1 by stimulating their GTPase activity
CC       (PubMed:7623849, PubMed:9422736). As part of the Ral signaling pathway,
CC       may also regulate ligand-dependent EGF and insulin receptors-mediated
CC       endocytosis (PubMed:10393179). During mitosis, may act as a scaffold
CC       protein in the phosphorylation of EPSIN/EPN1 by the mitotic kinase
CC       cyclin B-CDK1, preventing endocytosis during that phase of the cell
CC       cycle. During mitosis, also controls mitochondrial fission as an
CC       effector of RALA. Recruited to mitochondrion by RALA, acts as a
CC       scaffold to foster the mitotic kinase cyclin B-CDK1-mediated
CC       phosphorylation and activation of DNM1L (By similarity).
CC       {ECO:0000250|UniProtKB:Q15311, ECO:0000269|PubMed:10393179,
CC       ECO:0000269|PubMed:7623849, ECO:0000269|PubMed:9422736}.
CC   -!- FUNCTION: Could also function as a primary ATP-dependent active
CC       transporter for glutathione conjugates of electrophiles. May also
CC       actively catalyze the efflux of a wide range of substrates including
CC       xenobiotics like doxorubicin (DOX) contributing to cell multidrug
CC       resistance. {ECO:0000250|UniProtKB:Q15311}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an S-substituted glutathione(in) + ATP + H2O = ADP + an S-
CC         substituted glutathione(out) + H(+) + phosphate;
CC         Xref=Rhea:RHEA:19121, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:90779,
CC         ChEBI:CHEBI:456216; EC=7.6.2.3;
CC         Evidence={ECO:0000250|UniProtKB:Q15311};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19122;
CC         Evidence={ECO:0000250|UniProtKB:Q15311};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + xenobioticSide 1 = ADP + phosphate +
CC         xenobioticSide 2.; EC=7.6.2.2;
CC         Evidence={ECO:0000250|UniProtKB:Q15311};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + leukotriene C4(in) = ADP + H(+) + leukotriene
CC         C4(out) + phosphate; Xref=Rhea:RHEA:38963, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:57973, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:Q15311};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38964;
CC         Evidence={ECO:0000250|UniProtKB:Q15311};
CC   -!- SUBUNIT: Interacts with the GTP-bound form of RALA (via effector
CC       domain); during mitosis, recruits RALBP1 to the mitochondrion where it
CC       promotes DNM1L phosphorylation and mitochondrial fission
CC       (PubMed:7623849). Interacts with DNM1L; mediates its mitotic kinase
CC       cyclin B-CDK1-mediated phosphorylation during mitosis to promote
CC       mitochondrial fission. Interacts with the mitotic kinase cyclin B-CDK1
CC       during mitosis. Interacts with the GTP-bound form of RALB (via effector
CC       domain) (By similarity). Interacts with REPS1; the interaction is
CC       direct and does not affect RALA-binding nor GTPase activator activity
CC       of RALBP1 (PubMed:9395447). Interacts with REPS2; the interaction is
CC       direct and does not affect RALA-binding nor GTPase activator activity
CC       of RALBP1 (PubMed:9422736). Interacts with EPN1, NUMB and TFAP2A during
CC       interphase and mitosis. Interacts with AP2M1; as part of the AP2
CC       complex. Interacts with CDC42. Interacts with RAC1 (By similarity).
CC       {ECO:0000250|UniProtKB:Q15311, ECO:0000269|PubMed:7623849,
CC       ECO:0000269|PubMed:9395447, ECO:0000269|PubMed:9422736}.
CC   -!- INTERACTION:
CC       Q62796; P24385: CCND1; Xeno; NbExp=2; IntAct=EBI-3956409, EBI-375001;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q15311};
CC       Peripheral membrane protein {ECO:0000250|UniProtKB:Q15311}. Cytoplasm,
CC       cytosol {ECO:0000269|PubMed:9973605}. Cytoplasm, cytoskeleton, spindle
CC       pole {ECO:0000269|PubMed:9973605}. Nucleus
CC       {ECO:0000250|UniProtKB:Q15311}. Mitochondrion
CC       {ECO:0000250|UniProtKB:Q15311}. Note=Cytosolic protein that transiently
CC       associates with the mitotic spindle poles in early prophase, and
CC       dissociates from them after completion of mitosis (PubMed:9973605).
CC       Targeted to the plasma membrane through its interaction with RALB,
CC       directed by FGF signaling. Docking on the membrane is required to
CC       transduce the Ral signal (By similarity). Recruited by RALA to the
CC       mitochondrion during mitosis where it regulates mitochondrial fission.
CC       Nuclear localization is cell cycle dependent while membrane
CC       localization is seen in adherent cells. The region involved in membrane
CC       association could form transmembrane domains and expose a part of the
CC       protein extracellularly (By similarity). {ECO:0000250|UniProtKB:Q15311,
CC       ECO:0000250|UniProtKB:Q9PT60, ECO:0000269|PubMed:9973605}.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC       {ECO:0000269|PubMed:7623849}.
CC   -!- DOMAIN: The Rho-GAP domain mediates the GTPase activator activity
CC       toward CDC42. {ECO:0000305|PubMed:7623849}.
CC   -!- PTM: Tyrosine-phosphorylated upon stimulation of cells with EGF.
CC       {ECO:0000250|UniProtKB:Q62172}.
CC   -!- PTM: May undergo proteolytic cleavage to give peptides which reassemble
CC       to form a transporter complex. {ECO:0000250|UniProtKB:Q15311}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB91537.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U28830; AAA80654.1; -; mRNA.
DR   EMBL; U82623; AAB91537.1; ALT_FRAME; mRNA.
DR   PIR; A57467; A57467.
DR   RefSeq; NP_114456.1; NM_032067.1.
DR   AlphaFoldDB; Q62796; -.
DR   SMR; Q62796; -.
DR   BioGRID; 249880; 2.
DR   IntAct; Q62796; 3.
DR   MINT; Q62796; -.
DR   STRING; 10116.ENSRNOP00000033120; -.
DR   iPTMnet; Q62796; -.
DR   PhosphoSitePlus; Q62796; -.
DR   PaxDb; 10116-ENSRNOP00000033120; -.
DR   GeneID; 84014; -.
DR   KEGG; rno:84014; -.
DR   UCSC; RGD:621134; rat.
DR   AGR; RGD:621134; -.
DR   CTD; 10928; -.
DR   RGD; 621134; Ralbp1.
DR   eggNOG; KOG4370; Eukaryota.
DR   InParanoid; Q62796; -.
DR   OrthoDB; 24414at2759; -.
DR   PhylomeDB; Q62796; -.
DR   Reactome; R-RNO-9013148; CDC42 GTPase cycle.
DR   Reactome; R-RNO-9013149; RAC1 GTPase cycle.
DR   PRO; PR:Q62796; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0005739; C:mitochondrion; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; IDA:SynGO.
DR   GO; GO:0000922; C:spindle pole; IEA:UniProtKB-SubCell.
DR   GO; GO:0015431; F:ABC-type glutathione S-conjugate transporter activity; IEA:UniProtKB-EC.
DR   GO; GO:0008559; F:ABC-type xenobiotic transporter activity; IEA:UniProtKB-EC.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042626; F:ATPase-coupled transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0005096; F:GTPase activator activity; IDA:UniProtKB.
DR   GO; GO:0031267; F:small GTPase binding; IPI:UniProtKB.
DR   GO; GO:0022857; F:transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0042910; F:xenobiotic transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:1900753; P:doxorubicin transport; ISO:RGD.
DR   GO; GO:0006897; P:endocytosis; IMP:RGD.
DR   GO; GO:0048662; P:negative regulation of smooth muscle cell proliferation; IMP:RGD.
DR   GO; GO:0090141; P:positive regulation of mitochondrial fission; ISS:UniProtKB.
DR   GO; GO:1903378; P:positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway; IMP:RGD.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:0032489; P:regulation of Cdc42 protein signal transduction; IDA:UniProtKB.
DR   GO; GO:0099072; P:regulation of postsynaptic membrane neurotransmitter receptor levels; IDA:SynGO.
DR   GO; GO:0007264; P:small GTPase-mediated signal transduction; IPI:RGD.
DR   GO; GO:0055085; P:transmembrane transport; ISO:RGD.
DR   GO; GO:1990961; P:xenobiotic detoxification by transmembrane export across the plasma membrane; ISO:RGD.
DR   CDD; cd04381; RhoGap_RalBP1; 1.
DR   Gene3D; 1.20.58.90; -; 1.
DR   Gene3D; 1.10.555.10; Rho GTPase activation protein; 1.
DR   InterPro; IPR039767; RALBP1.
DR   InterPro; IPR049041; RalBP1-like_Ral-bd.
DR   InterPro; IPR008936; Rho_GTPase_activation_prot.
DR   InterPro; IPR000198; RhoGAP_dom.
DR   PANTHER; PTHR12783; RALA BINDING PROTEIN 1 RALBP1; 1.
DR   PANTHER; PTHR12783:SF5; RALA-BINDING PROTEIN 1; 1.
DR   Pfam; PF00620; RhoGAP; 1.
DR   Pfam; PF20924; RLIP76_Ral-bd; 1.
DR   SMART; SM00324; RhoGAP; 1.
DR   SUPFAM; SSF48350; GTPase activation domain, GAP; 1.
DR   PROSITE; PS50238; RHOGAP; 1.
PE   1: Evidence at protein level;
KW   Acetylation; ATP-binding; Cell cycle; Cell division; Cell membrane;
KW   Cytoplasm; Cytoskeleton; GTPase activation; Membrane; Mitochondrion;
KW   Mitosis; Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Translocase; Transport.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q15311"
FT   CHAIN           2..647
FT                   /note="RalA-binding protein 1"
FT                   /id="PRO_0000056735"
FT   DOMAIN          192..380
FT                   /note="Rho-GAP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00172"
FT   REGION          1..151
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          102..119
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250|UniProtKB:Q9PT60"
FT   REGION          154..219
FT                   /note="Mediates association with membranes and could form
FT                   transmembrane domains"
FT                   /evidence="ECO:0000250|UniProtKB:Q15311"
FT   REGION          163..186
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          403..499
FT                   /note="Mediates interaction with RALA and RALB"
FT                   /evidence="ECO:0000250|UniProtKB:Q15311"
FT   REGION          500..647
FT                   /note="Mediates interaction with REPS1 and REPS2"
FT                   /evidence="ECO:0000269|PubMed:9395447,
FT                   ECO:0000269|PubMed:9422736"
FT   REGION          525..550
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          601..647
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        49..70
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        115..151
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        601..615
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        633..647
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         69..74
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q15311"
FT   BINDING         418..425
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q15311"
FT   MOD_RES         2
FT                   /note="N-acetylthreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15311"
FT   MOD_RES         29
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15311"
FT   MOD_RES         30
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15311"
FT   MOD_RES         34
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15311"
FT   MOD_RES         44
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15311"
FT   MOD_RES         48
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         62
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         92
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15311"
FT   MOD_RES         93
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15311"
FT   MOD_RES         461
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15311"
FT   MOD_RES         463
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         637
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15311"
FT   CONFLICT        40
FT                   /note="E -> G (in Ref. 2; AAB91537)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        86
FT                   /note="V -> A (in Ref. 2; AAB91537)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        154
FT                   /note="F -> L (in Ref. 2; AAB91537)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        194
FT                   /note="F -> L (in Ref. 2; AAB91537)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        372
FT                   /note="L -> V (in Ref. 2; AAB91537)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        423
FT                   /note="F -> L (in Ref. 2; AAB91537)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        516
FT                   /note="R -> P (in Ref. 2; AAB91537)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   647 AA;  75252 MW;  7E6301E037B7F737 CRC64;
     MTECFLPPTS SPSEHRRAEH GSGLTRTPSS EEISPTKFPE LYRTGEPSPP HDILHEPPDI
     VSDDEKDHGK KKGKFKKKEK RTEGYVAFQE DSSGDEAESP SKMKRSKGIH VFKKPSFSKK
     KEKDFKIKEK PKEEKHKEEK HKEEKHKEKK CKDFTAADVV KQWKEKKKKK KPTQEPEVPQ
     TDAPSLRPIF GAPFADAVER TMMYDGIRLP AVFRECVDYM EKHGMKCEGI YRVSGIKSKV
     DELKAAYDRE ESPNLEEYEP NTVASLLKQY LRDLPENLLT KELMPRFEEA CGRTTEVEKV
     QEFQRLLREL PEYNHLLLSW LIVHMDHVIA KELETKMNIQ NISIVLSPTV QISNRVLYVL
     FTHVQELFGT VLLKQVTRPL RWSNMATMPT LPETQAGIKE EIRRQEFLLN CLHRDLQGGI
     KDFSKEERLW EVQRILTALK RKLREAKRQE CETKIAQEIA SLSKEDVSKE ETNENEEVIN
     ILLAQENEIL TEQEELLAME QFLRRQIASE KEEIDRLRAE IAEIQSRQHG RSETEEYSSD
     SESESEDEEE LQIILEDLQR QNEELEIKNN HLNQAVHEER EAIVELRVQL RLLQMLRAKS
     EQQLQEEEEP ERRGGTGPLP CEGVLEVRAA KEQAKPSPSK DRKETPI
//
